- Novo Nordisk sells hit weight-loss drug in China—at fraction of US price https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/ 208 comments economics
- Novo Nordisk sells hit weight-loss drug in China—at fraction of US price https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/ 203 comments technology
- Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a fraction of the US list price of $1,349, according to media reports. https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/ 36 comments technology
Linking pages
Linked pages
- Drugmaker to testify on why weight-loss drugs cost 15x more in the US | Ars Technica https://arstechnica.com/science/2024/06/drugmaker-ceo-to-testify-on-outrageously-priced-weight-loss-drugs/ 120 comments
- Report: DOJ wants to force Google Chrome sale, Android de-bundling - Ars Technica https://arstechnica.com/tech-policy/2024/11/report-doj-wants-to-force-google-chrome-sale-android-de-bundling/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Novo Nordisk sells hit weight-loss drug in China—at fraction of US price - Ars Technica
See how to search.